Many biotechs on the ASX talk alot... we're gunna do this and we're gunna do that. Biota stands out from the crowd, they actually deliver the goods. Be it a cure for the flu or just the common cold, Biota has an excellent pipeline in multi-billion dollar markets. There is no reason they won't be able to catch CSL's market cap in future and even overtake it. Won't happen this year though.
could move up soon, page-23
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)